CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues

Journal of Experimental Medicine

Volumn 207, Issue 1, 2010, Pages 223-235

  Budhu, Sadna ^a   Loike, John D ^a   Pandolfi, Ashley ^b   Han, Soo ^c   Catalano, Geoffrey ^a   Constantinescu, Andrei ^a   Clynes, Raphael ^a   Silverstein, Samuel C ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; FIBRIN; OVALBUMIN; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACTERICIDAL ACTIVITY; CANCER TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, CELLULAR; MELANOMA; MICE; MICE, TRANSGENIC;

EID: 76149114584     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091279     Document Type: Article

References (42)

1. Agger, R., M.S. Petersen, C.C. Petersen, S.B. Hansen, H. Stødkilde-Jørgensen, U. Skands, T. Blankenstein, T.E. Andersen, E.F. Hulgaard, J.T. Jørgensen, et al. 2007. T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J. Immunother. 30:29-39. doi:10.1097/01.cji.0000211326.38149.7e
2. Baramova, E.N., P. Coucke, P. Leprince, M.C. De Pauw-Gillet, R. Bassleer, and J.M. Foidart. 1994. Evaluation of matrix metalloproteinases and serine proteases activities in three B16 melanoma cell lines with distinct tumorigenic potential. Anticancer Res. 14:841-846.
3. Blattman, J.N., and P.D. Greenberg. 2006. PD-1 blockade: rescue from a near-death experience. Nat. Immunol. 7:227-228. doi:10.1038/ ni0306-227
4. Bronte, V., and S. Mocellin. 2009. Suppressive influences in the immune response to cancer. J. Immunother. 32:1-11. doi:10.1097/ CJI.0b013e3181837276
5. Brunner, K.T., J. Mauel, J.C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 14:181-196.
6. Buckanovich, R.J., A. Facciabene, S. Kim, F. Benencia, D. Sasaroli, K. Balint, D. Katsaros, A. O'Brien-Jenkins, P.A. Gimotty, and G. Coukos. 2008. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat. Med. 14:28-36. doi:10.1038/nm1699
7. Cerottini, J.C., H.D. Engers, H.R. Macdonald, and T. Brunner. 1974. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J. Exp. Med. 140:703-717. doi:10.1084/jem.140.3.703
8. Curtsinger, J.M., D.C. Lins, and M.F. Mescher. 1998. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J. Immunol. 160:3236-3243.
9. Daugherty, D.F., T.P. Pretlow, L.M. Peacock, A.M. Pitts, C.E. Mitchell, and T.G. Pretlow II. 1981. Separation and characterization of the neoplastic and stromal elements of the R3230AC mammary adenocarcinoma. Cancer Res. 41:5064-5069.
10. Dewever, J., F. Frérart, C. Bouzin, C. Baudelet, R. Ansiaux, P. Sonveaux, B. Gallez, C. Dessy, and O. Feron. 2007. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am. J. Pathol. 171:1619-1628. doi:10.2353/ajpath.2007.060968
11. Dobrzanski, M.J., J.B. Reome, and R.W. Dutton. 2001. Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cellmediated tumor rejection. Clin. Immunol. 98:70-84. doi:10.1006/ clim.2000.4945
12. Dudley, M.E., and S.A. Rosenberg. 2003. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer. 3:666-675. doi:10.1038/nrc1167
13. Dudley, M.E., J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 298:850-854. doi:10.1126/science. 1076514
14. Dvorak, H.F., J.A. Nagy, B. Berse, L.F. Brown, K.T. Yeo, T.K. Yeo, A.M. Dvorak, L. van de Water, T.M. Sioussat, and D.R. Senger. 1992. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N. Y. Acad. Sci. 667:101-111. doi:10.1111/ j.1749-6632.1992.tb51603. x
15. Freedman, V.H., T.E. Gorrell, C.F. Nathan, C.S. Copeland, and S.C. Silverstein. 1984. Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions. J. Exp. Med. 160:94-107. doi:10.1084/jem.160.1.94
16. Grabowska, M. 1959. Collagen content of normal connective tissue, of tissue surrounding a tumour and of growing rat sarcoma. Nature. 183:1186-1187. doi:10.1038/1831186a0
17. Hemstreet, G.P. III, P.G. Enoch, and T.G. Pretlow II. 1980. Tissue disaggregation of human renal cell carcinoma with further isopyknic and isokinetic gradient purification. Cancer Res. 40:1043-1049.
18. Hofmann, U.B., R. Houben, E.-B. Bröcker, and J.C. Becker. 2005. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie. 87:307-314. doi:10.1016/j.biochi.2005.01.013
19. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27. doi:10.1016/0092-8674(94)90169-4
20. Hu, F., and P.F. Lesney. 1964. The isolation and cytology of two pigment cell strains from B-16 mouse melanomas. Cancer Res. 24:1634-1643.
21. Huang, S.-C., C.-T. Ho, S.-Y. Lin-Shiau, and J.-K. Lin. 2005. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factorkappa B and c-Jun. Biochem. Pharmacol. 69:221-232. doi:10.1016/j.bcp .2004.09.019
22. Joseph-Pietras, D., A. Carlier, C. Madoulet, and P. Albert. 2006. Antitumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects. Melanoma Res. 16:325-333. doi:10.1097/01.cmr.0000205016.31235.a9
23. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156:3678-3686.
24. Kuwashima, Y., T. Yamada, M. Saio, and T. Takami. 1993. Growth characteristics of murine B16 melanoma multicellular spheroids: a model for invasion and effects of doxorubicin treatments. Anticancer Res. 13:1215-1217.
25. Le, D.T., P. Borgs, T.W. Toneff, M.H. Witte, and S.I. Rapaport. 1998. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am. J. Physiol. 274:H769-H776.
26. Li, X.H., G. Paulus, G. Atassi, and N. Buyssens. 1984. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1- nitrosourea (CCNU) at the initial stage after tumor transplantation. Am. J. Pathol. 115:403-411.
27. Li, Y., A. Karlin, J.D. Loike, and S.C. Silverstein. 2002. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc. Natl. Acad. Sci. USA. 99:8289-8294. doi:10.1073/ pnas.122244799
28. Li, Y., A. Karlin, J.D. Loike, and S.C. Silverstein. 2004. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J. Exp. Med. 200:613-622. doi:10.1084/jem.20040725
29. Lukacher, A.E., J.M. Moser, A. Hadley, and J.D. Altman. 1999. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J. Immunol. 163:3369-3378.
30. Martz, E. 1975. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization. J. Immunol. 115: 261-267.
31. Moore, M.W., F.R. Carbone, and M.J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:777-785. doi:10.1016/S0092-8674(88) 91043-4
32. Ochalek, T., F.J. Nordt, K. Tullberg, and M.M. Burger. 1988. Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res. 48:5124-5128.
33. Petersen, C.C., M.S. Petersen, R. Agger, and M.E. Hokland. 2006. Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection. J. Immunother. 29:241-249. doi:10.1097/01.cji.0000203078.97493.c3
34. Regoes, R.R., D.L. Barber, R. Ahmed, and R. Antia. 2007. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. USA. 104:1599-1603. doi:10.1073/pnas.0508830104
35. Snyder, J.E., W.J. Bowers, A.M. Livingstone, F.E. Lee, H.J. Federoff, and T.R. Mosmann. 2003. Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nat. Med. 9:231-235. doi:10.1038/nm821
36. Stephens, T.C., and J.H. Peacock. 1978. Cell yield and cell survival following chemotherapy of the B16 melanoma. Br. J. Cancer. 38:591-598.
37. Stuge, T.B., S.P. Holmes, S. Saharan, A. Tuettenberg, M. Roederer, J.S. Weber, and P.P. Lee. 2004. Diversity and recognition efficiency of T cell responses to cancer. PLoS Med. 1:e28. doi:10.1371/journal .pmed.0010028
38. Sutherland, R.M. 1988. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 240:177-184. doi:10.1126/science.2451290
39. Svedman, C., B.B. Yu, T.J. Ryan, and H. Svensson. 2002. Plasma proteins in a standardised skin mini-erosion (I): permeability changes as a function of time. BMC Dermatol. 2:3. doi:10.1186/1471-5945-2-3
40. Takeda, Y., and A.Y. Chen. 1967. Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A. J. Clin. Invest. 46:1979-1985.
41. Virgin, H.W., E.J. Wherry, and R. Ahmed. 2009. Redefining chronic viral infection. Cell. 138:30-50. doi:10.1016/j.cell.2009.06.036
42. Whiteside, T.L., S. Miescher, H.R. MacDonald, and V. Von Fliedner. 1986. Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J. Immunol. Methods. 90:221-233. doi:10.1016/0022-1759(86) 90079-7